BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19546174)

  • 21. Cardioprotection by pre-infarct angina: is it ischaemic preconditioning?
    Dana A; Yellon DM
    Eur Heart J; 1998 Mar; 19(3):367-9. PubMed ID: 9568437
    [No Abstract]   [Full Text] [Related]  

  • 22. Response to Letter Regarding Article, "Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism".
    Noguchi T; Yasuda S; Shibata T; Kawakami S; Tanaka T; Asaumi Y; Kanaya T; Nagai T; Nakao K; Fujino M; Nagatsuka K; Ishibashi-Ueda H; Nishimura K; Miyamoto Y; Kusano K; Anzai T; Goto Y; Ogawa H
    Circulation; 2016 Feb; 133(5):e379. PubMed ID: 26831444
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter by Nadir Regarding Article, "Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism".
    Nadir MA
    Circulation; 2016 Feb; 133(5):e378. PubMed ID: 26831443
    [No Abstract]   [Full Text] [Related]  

  • 24. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular images. A novel real-time fluorescent optical imaging system in mouse heart: a powerful tool for studying coronary circulation and cardiac function.
    Hattori H; Higuchi K; Nogami Y; Amano Y; Ishihara M; Takase B
    Circ Cardiovasc Imaging; 2009 May; 2(3):277-8. PubMed ID: 19808603
    [No Abstract]   [Full Text] [Related]  

  • 26. [Non-atherosclerotic acute myocardial infarction: coronary artery embolism].
    López-Lluva MT; Sánchez-Pérez I; Fernández-Vallejo V; Pinilla-Echeverri N; del Campo-Tejedor R; Ambrós-Checa A
    Med Intensiva; 2013 Apr; 37(3):209-11. PubMed ID: 22824132
    [No Abstract]   [Full Text] [Related]  

  • 27. Embolic Myocardial Infarction as a Consequence of Atrial Fibrillation: A Prevailing Disease of the Future.
    Kolodgie FD; Virmani R; Finn AV; Romero ME
    Circulation; 2015 Jul; 132(4):223-6. PubMed ID: 26216083
    [No Abstract]   [Full Text] [Related]  

  • 28. Surgical recanalization for treatment of evolving myocardial infarction.
    Bergmann SR; Sobel BE
    Ann Thorac Surg; 1989 Sep; 48(3):319-21. PubMed ID: 2774713
    [No Abstract]   [Full Text] [Related]  

  • 29. Myocardial reperfusion injury.
    Forman MB; Jackson EK
    N Engl J Med; 2007 Dec; 357(23):2408; author reply 2409-10. PubMed ID: 18069133
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.
    De Hert S; Vlasselaers D; Barbé R; Ory JP; Dekegel D; Donnadonni R; Demeere JL; Mulier J; Wouters P
    Anaesthesia; 2009 Sep; 64(9):953-60. PubMed ID: 19686479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why does pre-clinical success in cardioprotection fail at the bedside?
    Tritto I; Ambrosio G
    Cardiovasc Res; 2016 Feb; 109(2):189-90. PubMed ID: 26705363
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
    Stumpner J; Redel A; Kellermann A; Lotz CA; Blomeyer CA; Smul TM; Kehl F; Roewer N; Lange M
    Anesthesiology; 2009 Dec; 111(6):1257-64. PubMed ID: 19934869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of nitric oxide in A3 adenosine receptor-mediated cardioprotection.
    Hussain A; Karjian P; Maddock H
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):97-104. PubMed ID: 19566749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between pre- and postconditioning in the in vivo rat heart.
    Manintveld OC; Hekkert Mt; van der Ploeg NT; Verdouw PD; Duncker DJ
    Exp Biol Med (Maywood); 2009 Nov; 234(11):1345-54. PubMed ID: 19657069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
    Sodhi RK; Singh M; Singh N; Jaggi AS
    Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clotting system in the reperfused coronary circulation].
    Schrör K
    Dtsch Med Wochenschr; 2008 Mar; 133(12):579-81. PubMed ID: 18335385
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coronary artery diseases. Reflecting management advances in the daily reality of the disease].
    Weber S
    Rev Prat; 2008 Sep; 58(14):1519-21. PubMed ID: 18839679
    [No Abstract]   [Full Text] [Related]  

  • 39. Myocardial reperfusion injury.
    Lowenstein CJ
    N Engl J Med; 2007 Dec; 357(23):2409; author reply 2409-10. PubMed ID: 18069136
    [No Abstract]   [Full Text] [Related]  

  • 40. [Inflammatory mechanisms associated with acute coronary syndrome].
    Emanuelli G; Montrucchio G; Alloatti G; Orzan F; Conte MR; Lucchina PG; Camussi G; Brusca A; Battaglia CL; Brusca R
    Cardiologia; 1995 Dec; 40(12 Suppl 1):389-93. PubMed ID: 8998743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.